LMAT Quote, Financials, Valuation and Earnings

Intuitive Surgical has a net margin of 20.07% compared to LeMaitre Vascular's net margin of 30.99%. LeMaitre Vascular's return on equity of 13.81% beat Intuitive Surgical's return on equity of 15.82%.

LeMaitre Vascular has a consensus price target of $105.63, signalling upside risk potential of 15.3%. On the other hand Intuitive Surgical has an analysts' consensus of $576.03 which suggests that it could grow by 11.94%. Given that LeMaitre Vascular has higher upside potential than Intuitive Surgical, analysts believe LeMaitre Vascular is more attractive than Intuitive Surgical.

LeMaitre Vascular has a beta of 0.887, which suggesting that the stock is 11.293% less volatile than S&P 500. In comparison Intuitive Surgical has a beta of 1.555, suggesting its more volatile than the S&P 500 by 55.506%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.74%. Intuitive Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Intuitive Surgical pays out -- of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $55.7M, which are smaller than Intuitive Surgical quarterly revenues of $2.3B. LeMaitre Vascular's net income of $11.2M is lower than Intuitive Surgical's net income of $698.4M. Notably, LeMaitre Vascular's price-to-earnings ratio is 47.22x while Intuitive Surgical's PE ratio is 75.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 9.49x versus 21.44x for Intuitive Surgical. Usually stocks with elevated PS ratios are considered overvalued.

Masimo has a net margin of 20.07% compared to LeMaitre Vascular's net margin of -58.2%. LeMaitre Vascular's return on equity of 13.81% beat Masimo's return on equity of -23.05%.

LeMaitre Vascular has a consensus price target of $105.63, signalling upside risk potential of 15.3%. On the other hand Masimo has an analysts' consensus of $195.70 which suggests that it could grow by 19.52%. Given that Masimo has higher upside potential than LeMaitre Vascular, analysts believe Masimo is more attractive than LeMaitre Vascular.

LeMaitre Vascular has a beta of 0.887, which suggesting that the stock is 11.293% less volatile than S&P 500. In comparison Masimo has a beta of 1.278, suggesting its more volatile than the S&P 500 by 27.807%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.74%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $55.7M, which are smaller than Masimo quarterly revenues of $600.7M. LeMaitre Vascular's net income of $11.2M is higher than Masimo's net income of -$349.6M. Notably, LeMaitre Vascular's price-to-earnings ratio is 47.22x while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 9.49x versus 4.23x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.

Insulet has a net margin of 20.07% compared to LeMaitre Vascular's net margin of 16.85%. LeMaitre Vascular's return on equity of 13.81% beat Insulet's return on equity of 43.11%.

LeMaitre Vascular has a consensus price target of $105.63, signalling upside risk potential of 15.3%. On the other hand Insulet has an analysts' consensus of $312.27 which suggests that it could grow by 19.78%. Given that Insulet has higher upside potential than LeMaitre Vascular, analysts believe Insulet is more attractive than LeMaitre Vascular.

LeMaitre Vascular has a beta of 0.887, which suggesting that the stock is 11.293% less volatile than S&P 500. In comparison Insulet has a beta of 1.300, suggesting its more volatile than the S&P 500 by 30.008%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.74%. Insulet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Insulet pays out -- of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $55.7M, which are smaller than Insulet quarterly revenues of $597.5M. LeMaitre Vascular's net income of $11.2M is lower than Insulet's net income of $100.7M. Notably, LeMaitre Vascular's price-to-earnings ratio is 47.22x while Insulet's PE ratio is 45.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 9.49x versus 9.30x for Insulet. Usually stocks with elevated PS ratios are considered overvalued.

Teleflex has a net margin of 20.07% compared to LeMaitre Vascular's net margin of -17.18%. LeMaitre Vascular's return on equity of 13.81% beat Teleflex's return on equity of 1.57%.

LeMaitre Vascular has a consensus price target of $105.63, signalling upside risk potential of 15.3%. On the other hand Teleflex has an analysts' consensus of $161.82 which suggests that it could grow by 19.68%. Given that Teleflex has higher upside potential than LeMaitre Vascular, analysts believe Teleflex is more attractive than LeMaitre Vascular.

LeMaitre Vascular has a beta of 0.887, which suggesting that the stock is 11.293% less volatile than S&P 500. In comparison Teleflex has a beta of 1.191, suggesting its more volatile than the S&P 500 by 19.095%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.74%. Teleflex offers a yield of 1.01% to investors and pays a quarterly dividend of $0.34 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Teleflex pays out 91.2% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $55.7M, which are smaller than Teleflex quarterly revenues of $795.4M. LeMaitre Vascular's net income of $11.2M is higher than Teleflex's net income of -$136.7M. Notably, LeMaitre Vascular's price-to-earnings ratio is 47.22x while Teleflex's PE ratio is 95.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 9.49x versus 2.09x for Teleflex. Usually stocks with elevated PS ratios are considered overvalued.